Stay updated on Subcutaneous Lirentelimab in Atopic Dermatitis Clinical Trial

Sign up to get notified when there's something new on the Subcutaneous Lirentelimab in Atopic Dermatitis Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Subcutaneous Lirentelimab in Atopic Dermatitis Clinical Trial page

  1. Check
    8 days ago
    Change Detected
    Summary
    Added a comprehensive Locations section listing study sites across multiple states (Alabama, Arizona, California, Colorado, District of Columbia, Florida, Kentucky, Louisiana, Maryland, Massachusetts, Minnesota, Montana, Nebraska, Nevada, New York, Ohio, Oklahoma, Oregon, Pennsylvania, Texas, Utah, Washington) and included the Revision: v3.3.3 label.
    Difference
    2%
    Check dated 2025-12-24T14:34:57.000Z thumbnail image
  2. Check
    15 days ago
    No Change Detected
  3. Check
    22 days ago
    No Change Detected
  4. Check
    37 days ago
    Change Detected
    Summary
    The page revision history shows an update from v3.2.0 to v3.3.2, a minor metadata change that does not affect study content, eligibility criteria, or results. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2025-11-25T14:44:39.000Z thumbnail image
  5. Check
    44 days ago
    Change Detected
    Summary
    The site-wide funding status notice about government operations was removed from this page. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2025-11-18T07:28:45.000Z thumbnail image
  6. Check
    65 days ago
    Change Detected
    Summary
    The Study Details page for NCT05155085 appears unchanged between the two screenshots, with no visible edits to study design, eligibility criteria, outcomes, or site list.
    Difference
    0.3%
    Check dated 2025-10-27T20:58:01.000Z thumbnail image
  7. Check
    87 days ago
    Change Detected
    Summary
    Summary of changes: updated operating-status notice and a version bump to v3.2.0, replacing the previous v3.1.0.
    Difference
    3%
    Check dated 2025-10-06T08:11:33.000Z thumbnail image
  8. Check
    94 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.1.0 and removes several drug-safety topics (Drug Safety, Counterfeit Drugs, Pharmaceutical Preparations, Substandard Drugs) from the content, indicating a restructuring and possible narrowing of the domain coverage.
    Difference
    0.4%
    Check dated 2025-09-29T04:37:42.000Z thumbnail image

Stay in the know with updates to Subcutaneous Lirentelimab in Atopic Dermatitis Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Subcutaneous Lirentelimab in Atopic Dermatitis Clinical Trial page.